Bicistronic Construct for Optogenetic Prosthesis of Ganglion Cell Receptive Field of Degenerative Retina
- Авторы: Petrovskaya L.E.1,2, Roshchin M.V.3, Smirnova G.R.3, Kolotova D.E.3,4, Balaban P.M.3, Ostrovsky M.A.4,5, Malyshev A.Y.3
-
Учреждения:
- Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
- Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
- Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
- Faculty of Biology, Moscow State University
- Emanuel Institute of Biochemical Physics, Russian Academy of Sciences
- Выпуск: Том 486, № 1 (2019)
- Страницы: 184-186
- Раздел: Biochemistry, Biophysics, and Molecular Biology
- URL: https://journals.rcsi.science/1607-6729/article/view/213001
- DOI: https://doi.org/10.1134/S1607672919030062
- ID: 213001
Цитировать
Аннотация
To perform optogenetic prosthetics of the retinal ganglion cell receptive field, a bicistronic genetic construct carrying the genes encoding the excitatory (channelrhodopsin-2) and inhibitory (Guillardia theta anion channelrhodopsin GtACR2) rhodopsins was created. A characteristic feature of this construct was the combination of these two genes with a mutant IRES insertion between them, which ensures the exact ratio of expression levels of the first and second genes in each transfected cell. Illumination of the central part of the neuron with light with a wavelength of 470 nm induced the action potential generation in the cell. Stimulation of the peripheral neuronal region with light induced the inhibition of action potential generation. Thus, using optogenetics methods, we simulated the ON–OFF interaction in the retinal ganglion cell receptive field. Theoretically, this construct can be used for optogenetic prosthetics of degenerative retina in the case of its delivery to the ganglion cells with lentiviral vectors.
Об авторах
L. Petrovskaya
Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation; Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
Email: malyshev@ihna.ru
Россия, Moscow, 117997; Moscow, 117997
M. Roshchin
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Email: malyshev@ihna.ru
Россия, Moscow, 117485
G. Smirnova
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Email: malyshev@ihna.ru
Россия, Moscow, 117485
D. Kolotova
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences; Faculty of Biology, Moscow State University
Email: malyshev@ihna.ru
Россия, Moscow, 117485; Moscow, 119234
P. Balaban
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Email: malyshev@ihna.ru
Россия, Moscow, 117485
M. Ostrovsky
Faculty of Biology, Moscow State University; Emanuel Institute of Biochemical Physics, Russian Academy of Sciences
Email: malyshev@ihna.ru
Россия, Moscow, 119234; Moscow, 119334
A. Malyshev
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Автор, ответственный за переписку.
Email: malyshev@ihna.ru
Россия, Moscow, 117485
Дополнительные файлы
